Showing results (281-290 of 295) with videos related to
Sort By:
Pageof 30
British Journal of Haematology|April 1, 1997
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stageA C Rawstron, R G Owen, F E Davies, et al.British Journal of Haematology|January 31, 1998
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trialD C Linch, D W Milligan, D A Winfield, et al.British Journal of Haematology|March 22, 2001
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myelomaF E Davies, P D Forsyth, A C Rawstron, et al.Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.Cancer Chemotherapy and Pharmacology|January 6, 2004
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimenP Moreton, G J Morgan, D Gilson, et al.Nature Communications|November 22, 2019
Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptorsCatarina F Almeida, Srinivasan Sundararaj, Jérôme Le Nours, et al.Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|November 26, 2008
Regulatory supervision of sites for spent fuel and radioactive waste storage in the Russian northwestN K Shandala, M K Sneve, G M Smith, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancerR L Ward, D Packham, A M Smythe, et al.Hematological Oncology|October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvestsF E Davies, A C Rawstron, G Pratt, et al.Pageof 30